qualified testing

(1)The term “qualified testing” means— (A)human clinical testing— (i)which is carried out under an exemption for a drug for a rare disease or condition undersection 355(i) of this title(or regulations issued under such section); and (ii)which occurs before the date on which an application with respect to such drug is submitted undersection 355(b) of this titleor undersection 262 of title 42; (B)preclinical testing involving a drug for a rare disease or condition which occurs after the date such drug is designated undersection 360bb of this titleand before the date on which an application with respect to such drug is submitted undersection 355(b) of this titleor undersection 262 of title 42; and (C)prospectively planned and designed observational studies and other analyses conducted to assist in the understanding of the natural history of a rare disease or condition and in the development of a therapy, including studies and analyses to— (i)develop or validate a drug development tool related to a rare disease or condition; or (ii)understand the full spectrum of the disease manifestations, including describing genotypic and phenotypic variability and identifying and defining distinct subpopulations affected by a rare disease or condition.

Source

21 USC § 360ee(b)(1)


Scoping language

For purposes of subsection
Is this correct? or